Patents by Inventor Robin David Grey Cooper

Robin David Grey Cooper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Teicoplanin deacylation process and product
    Patent number: 5936074
    Abstract: The present invention is directed to deacyl teicoplanin, and to a process for preparing deacyl teicoplanin by reacting teicoplanin with ECB deacylase. Deacyl teicoplanin can be alkylated to produce compounds useful for their antibacterial activity.
    Type: Grant
    Filed: April 1, 1998
    Date of Patent: August 10, 1999
    Assignee: Eli Lilly and Company
    Inventors: Barbara Shreve Briggs, Robin David Grey Cooper, Adam Joseph Kreuzman, Milton Joseph Zmijewski, Jr.
  • Amides
    Patent number: 5919756
    Abstract: The present invention is directed to amides of antibiotic A82846B (also known as chloroorienticin A), and of N.sup.4 -derivatives of A82846B. The present amide compounds are useful as antibacterials, especially for the control of gram positive bacteria; the compounds are particularly useful for the control of resistant bacterial strains, such as vancomycin-resistant-enterococci ("VRE").
    Type: Grant
    Filed: May 1, 1997
    Date of Patent: July 6, 1999
    Assignee: Eli Lilly and Company
    Inventors: Robin David Grey Cooper, Michael John Rodriguez, Nancy June Snyder, Mark James Zweifel
  • Teicoplanin derivatives
    Patent number: 5916873
    Abstract: The present invention is directed to teicoplanin derivatives of the following general formula, wherein R.sup.1 and R.sup.2 are as defined in the specification. ##STR1## These derivatives are useful as antibiotics for the control of gram-positive bacteria.
    Type: Grant
    Filed: April 1, 1998
    Date of Patent: June 29, 1999
    Assignee: Eli Lilly and Company
    Inventors: Robin David Grey Cooper, Nancy June Snyder